🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Status
Recruiting
Location
Nkarta Investigational Site
Start Date
2024-06-13
Trial ID
NCT06557265
Treatments Being Tested
Breast cancer is the second most common invasive malignancy and the leading...
Status
Terminated
Location
Hospital del Mar
Start Date
2022-05-11
Trial ID
NCT05385705
Treatments Being Tested
This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-10
Trial ID
NCT05182073
This is a phase I/II clinical trial using adoptive cell therapy with NK cel...
Status
Completed
Location
Hospital Universitario La Paz
Start Date
2020-09-04
Trial ID
NCT04578210
Treatments Being Tested
This phase II clinical trial studies how well personalized natural killer (...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-05-19
Trial ID
NCT02727803
This phase I trial studies the side effects and best dose of cord blood-der...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2018-08-31
Trial ID
NCT03420963
Treatments Being Tested
The main goal of this study is to evaluate the anti-relapse prophylactic ac...
Status
Completed
Location
Hospital Universitario de Cruces
Start Date
2016-05
Trial ID
NCT02763475
Treatments Being Tested